These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24858856)
21. Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin. Liu J; Miao G; Wang B; Zheng N; Ma L; Chen X; Wang G; Zhao X; Zhang L; Zhang L Biochem Biophys Res Commun; 2018 Mar; 497(2):742-748. PubMed ID: 29462613 [TBL] [Abstract][Full Text] [Related]
22. Losartan protects against myocardial ischemia and reperfusion injury Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833 [TBL] [Abstract][Full Text] [Related]
23. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. Alghisi GC; Ponsonnet L; Rüegg C PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436 [TBL] [Abstract][Full Text] [Related]
24. Association of Csk to VE-cadherin and inhibition of cell proliferation. Baumeister U; Funke R; Ebnet K; Vorschmitt H; Koch S; Vestweber D EMBO J; 2005 May; 24(9):1686-95. PubMed ID: 15861137 [TBL] [Abstract][Full Text] [Related]
25. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation. Duong CN; Nottebaum AF; Butz S; Volkery S; Zeuschner D; Stehling M; Vestweber D Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):378-393. PubMed ID: 31826650 [TBL] [Abstract][Full Text] [Related]
26. Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions. Rho SS; Ando K; Fukuhara S J Nippon Med Sch; 2017; 84(4):148-159. PubMed ID: 28978894 [TBL] [Abstract][Full Text] [Related]
27. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Miyazaki T; Taketomi Y; Takimoto M; Lei XF; Arita S; Kim-Kaneyama JR; Arata S; Ohata H; Ota H; Murakami M; Miyazaki A Circulation; 2011 Dec; 124(23):2522-32. PubMed ID: 22064597 [TBL] [Abstract][Full Text] [Related]
28. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825 [TBL] [Abstract][Full Text] [Related]
29. CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin. Lugano R; Vemuri K; Barbera S; Orlandini M; Dejana E; Claesson-Welsh L; Dimberg A FASEB J; 2023 Apr; 37(4):e22894. PubMed ID: 36961390 [TBL] [Abstract][Full Text] [Related]
30. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade. Lee SW; Won JY; Lee HY; Lee HJ; Youn SW; Lee JY; Cho CH; Cho HJ; Oh S; Chae IH; Kim HS Mol Med; 2011; 17(9-10):1095-106. PubMed ID: 21738954 [TBL] [Abstract][Full Text] [Related]
31. Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2. Wan R; Guo R; Chen C; Jin L; Zhu C; Zhang Q; Xu Y; Li S J Cell Physiol; 2013 Jun; 228(6):1295-303. PubMed ID: 23168683 [TBL] [Abstract][Full Text] [Related]
32. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models. Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753 [TBL] [Abstract][Full Text] [Related]
34. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350 [TBL] [Abstract][Full Text] [Related]
35. CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin. Hou WH; Liu IH; Tsai CC; Johnson FE; Huang SS; Huang JS J Cell Sci; 2011 Apr; 124(Pt 8):1231-44. PubMed ID: 21444752 [TBL] [Abstract][Full Text] [Related]
36. The role of VE-cadherin in vascular morphogenesis and permeability control. Dejana E; Vestweber D Prog Mol Biol Transl Sci; 2013; 116():119-44. PubMed ID: 23481193 [TBL] [Abstract][Full Text] [Related]
38. Effect of melatonin on EGF- and VEGF-induced monolayer permeability of HUVECs. Yang L; Zhang Y; Ma Y; Du J; Gu L; Zheng L; Zhang X Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1178-H1191. PubMed ID: 30575440 [TBL] [Abstract][Full Text] [Related]
39. Plakoglobin maintains the integrity of vascular endothelial cell junctions and regulates VEGF-induced phosphorylation of VE-cadherin. Muramatsu F; Kidoya H; Naito H; Hayashi Y; Iba T; Takakura N J Biochem; 2017 Jul; 162(1):55-62. PubMed ID: 28158602 [TBL] [Abstract][Full Text] [Related]
40. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions. Friedrich EE; Hong Z; Xiong S; Zhong M; Di A; Rehman J; Komarova YA; Malik AB Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12980-12985. PubMed ID: 31186359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]